Hepatitis C: an update.

Détails

Ressource 1Télécharger: 11584690.pdf (411.61 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_4B2C50C88F58
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Hepatitis C: an update.
Périodique
Swiss medical weekly
Auteur(s)
Moradpour D., Cerny A., Heim M.H., Blum H.E.
ISSN
1424-7860 (Print)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
02/06/2001
Peer-reviewed
Oui
Volume
131
Numéro
21-22
Pages
291-298
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. While current therapeutic options for hepatitis C are limited, recent progress in the understanding of the biology of HCV led to the identification of novel targets for antiviral intervention. In addition, molecular and immunotherapeutic strategies to inhibit HCV replication or gene expression and to enhance the cellular immune response against HCV are being explored. These and other novel antiviral strategies may eventually complement existing therapeutic modalities. Here, we briefly review current concepts of the epidemiology, molecular virology, pathogenesis, natural history, diagnosis, therapy, and prevention of hepatitis C.

Mots-clé
Antiviral Agents/therapeutic use, Enzyme-Linked Immunosorbent Assay, Hepacivirus/isolation & purification, Hepatitis C/diagnosis, Hepatitis C/epidemiology, Hepatitis C/therapy, Humans, Reverse Transcriptase Polymerase Chain Reaction
Pubmed
Web of science
Création de la notice
25/01/2008 17:05
Dernière modification de la notice
20/08/2019 14:59
Données d'usage